Multicenter Registry Study With Therapeutic Hypothermia After Cardiac Arrest in Japan (J-PULSE-HYPO)

Recently, early defibrillation and cardiopulmonary resuscitation (CPR) for sudden onset of cardiac arrest are advancing, however, survival rate is still very low in the world. Furthermore, post-cardiac arrest brain injury is a common cause of morbidity and mortality after successful resuscitation which is urgent issue to be solved. Therapeutic hypothermia is part of a standardized treatment strategy for comatose survivors of cardiac arrest in the metabolic phase usually about 15 minutes after cardiac arrest. However, the evidences of the efficacy of therapeutic hypothermia are still few. The optimal candidates, temperature, the timing of initiation, the therapeutic windows and the rate for rewarming have not been defined clinically and should be established. The purpose of this research is the improvement in the outcomes for patients with coma after resuscitation from out-of-hospital cardiac arrest using therapeutic hypothermia established from the analysis of multicenter registry data.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

452

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hiroshima, Japan
        • Hiroshima City Hospital
      • Osaka, Japan
        • Osaka City General Hospital
      • Osaka, Japan
        • Osaka Police Hospital
      • Osaka, Japan
        • Sumitomo Hospital
      • Saga, Japan
        • Saga University Hospital
      • Tokyo, Japan
        • Nihon University Surugadai Hospital
    • Fukuoka
      • Kitakyushu, Fukuoka, Japan
        • Kokura Memorial Hospital
    • Hokaido
      • Sapporo, Hokaido, Japan
        • Sapporo City University Hopistal
    • Kagawa
      • Takamatsu, Kagawa, Japan
        • Kagawa University Hospital
    • Kanagawa
      • Yokohama, Kanagawa, Japan
        • Yokohama City University Medical Center
    • Osaka
      • Suita, Osaka, Japan, 565-8565
        • National Cardiovascular Center
      • Suita, Osaka, Japan
        • Osaka Saiseikai Senri Hospital
      • Takatsuki, Osaka, Japan
        • Osaka Mishima Emergency Critical Care Center
    • Yamaguchi
      • Ube, Yamaguchi, Japan
        • Yamaguchi University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with therapeutic hypothermia after cardiac arrest from 2005 to 2009 in each hospitals.

Description

Inclusion Criteria:

  • Adult patients who remained unconscious after resuscitation from out-of-hospital or inhospital cardiac arrest
  • Presented the stable hemodynamics with drug treatments or mechanical supporting system including IABP or PCPS

Exclusion Criteria:

  • Patients with:

    • pregnancy
    • acute aortic dissection
    • pulmonary thromboembolism
    • drug poisoning
    • poor daily activity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
hypothermia
Patients with therapeutic hypothermia after cardiac arrest in hospitals

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Survival and functional outcome (CPC: Cerebral Performance Categories)
Time Frame: after 3 months
after 3 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Survival and/or functional outcome
Time Frame: after 24 hours
after 24 hours
Survival and/or functional outcome
Time Frame: after 7 days
after 7 days
Survival and/or functional outcome
Time Frame: after one month
after one month
Survival and/or functional outcome
Time Frame: at discharge
at discharge
Survival or functional outcome
Time Frame: after three months
after three months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hiroshi Nonogi, MD, Department of Cardiology, National Cardiovascular Center , Japan

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2008

Primary Completion (Actual)

March 1, 2010

Study Completion (Actual)

July 1, 2011

Study Registration Dates

First Submitted

May 12, 2009

First Submitted That Met QC Criteria

May 12, 2009

First Posted (Estimate)

May 13, 2009

Study Record Updates

Last Update Posted (Estimate)

July 22, 2011

Last Update Submitted That Met QC Criteria

July 21, 2011

Last Verified

July 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • NCVC-JPULSE-H
  • UMIN000001935

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Arrest

3
Subscribe